W
WAVEMAN · COMPANY
EMN · Eastman Chemical Co
> Ask across nine datasets ⌘K
LIVE
TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475
← ALL COMPANIES

EMN

EASTMAN CHEMICAL CO
PHARMA & BIOTECH · PLASTIC MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS · CIK 0000915389
FORM 144 · 1☆ WATCH
INSIDER NET · 180D
-$365.8K
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
0
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
331
13F, latest reported quarter
REVENUE GROWTH
-6.7%
XBRL, annual
NET MARGIN
5.4%
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net -$365.8K over 180 days
-$234.1K over 90 days
below 53% of Pharma & Biotech
CONGRESS
no member of Congress has reported trading it
FUNDS
331 funds added or opened last quarter
more than 94% of Pharma & Biotech
REVENUE
-6.7% year over year
below 67% of Pharma & Biotech
MARGIN
5.4% net margin
more than 74% of Pharma & Biotech
BUYBACKS
no share repurchases reported
SHORT
4.6% of shares outstanding short · 3.8 days to cover · settled 2026-07-31
more than 51% of Pharma & Biotech
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
331 funds added or opened positions in the latest 13F quarter, of 649 holders.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN +7.7%
+7.7%12M
-18%-5%+8%+20%2025-092025-102025-122026-032026-052026-072026-09 2026-08-04 · Holt Adrian James sold $234.1K2026-05-05 · Holt Adrian James sold $131.7K2026-08-04 · Holt Adrian James filed to sell $234.1K
INSIDER SELLFORM 144
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
Insiders have filed to sell — before selling.
The record shows a net $365.8K sold by insiders over 180 days, 331 funds added last quarter, $234.1K in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, EASTMAN CHEMICAL CO insiders sold a net $365.8K of stock across 48 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER
FILED
SHARES
VALUE
Holt Adrian James
SVP, Chf HR Ofcr
SELL
2026-08-04
3,283.0
$234.1K
Holt Adrian James
SVP, Chf HR Ofcr
SELL
2026-05-05
1,709.0
$131.7K
SMITH BRIAN TRAVIS
EVP, AFP, Mfg., WWEC & HSE
BUY
2025-08-27
1,750.0
$119.6K
OBRIEN JAMES J /KY
Director
BUY
2025-08-27
1,450.0
$99.8K
Mink Kim Ann
Director
BUY
2025-08-27
1,450.0
$100.6K
48 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 43 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
BlackRock, Inc.
16,936,709.0 sh
$1.1B
VANGUARD PORTFOLIO MANAGEMENT LLC
7,553,898.0 sh
$506.0M
DIMENSIONAL FUND ADVISORS LP
5,163,630.0 sh
$345.9M
VANGUARD CAPITAL MANAGEMENT LLC
5,160,164.0 sh
$345.6M
STATE STREET CORP
4,169,105.0 sh
$282.7M
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
Planned sales · Form 144
Filed before the sale — intent, not a trade
Holt Adrian James
FILED 2026-08-04
$234.1K
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
Invesco S&P SmallCap Materials ETF
$1.7M POSITION · AS OF 2026-02-28
8.8%
Amplify Energy & Natural Resources Covered Call ETF
$1.2M POSITION · AS OF 2026-03-31
4.5%
First Trust Materials AlphaDEX Fund
$16.7M POSITION · AS OF 2026-04-30
4.3%
Motley Fool Small-Cap Growth ETF
$2.0M POSITION · AS OF 2026-02-28
2.9%
NAA SMALL CAP VALUE SERIES
$1.2M POSITION · AS OF 2026-03-31
2.4%
DAVENPORT VALUE & INCOME FUND
$23.3M POSITION · AS OF 2026-03-31
2.3%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Corporate PAC
FEC · the company-connected political action committee's own receipts and spending — committee totals only, never individual donors
Eastmanpac-Political Action Committee Of Eastman Chemical Company
CYCLE 2026 · $261K SPENT
$298.2K
FEDERAL ELECTION COMMISSION · MATCHED BY THE PAC'S CONNECTED ORGANISATION
Executive pay vs shareholder return · Mark J. Costa
DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself
FY
CEO TOTAL
ACTUALLY PAID
OTHER NEOs AVG
TSR
PEER TSR
2025
$19.5M
-$5.8M
$5.1M
-24%
+19%
2024
$15.9M
$22.8M
$4.6M
+4%
+22%
2023
$17.6M
$17.0M
$4.8M
-1%
+24%
2022
$17.1M
$12.0M
$4.4M
-14%
+11%
2021
$17.8M
$33.7M
$5.4M
+24%
+26%
TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · GREEN WHERE THE COMPANY BEAT ITS OWN PEER GROUP
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$8.8B$9.4B$9.2B$10.6B
GROSS PROFIT$1.8B$2.3B$2.1B$2.1B
NET INCOME$474.0M$905.0M$894.0M$793.0M
EPS (DILUTED)4.107.677.496.35
OPERATING CASH FLOW$970.0M$1.3B$1.4B$975.0M
CASH$566.0M$837.0M$548.0M$493.0M
LONG-TERM DEBT$4.2B$4.6B$4.3B$4.0B
DIVIDENDS PAID$381.0M$379.0M$376.0M$381.0M
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-06 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-06 ALL SYSTEMS LIVE FOR MACHINES →